Coadministration of interleukin 12 expression vector with antigen 2 cDNA enhances induction of protective immunity against Coccidioides immitis

Infection and Immunity

Volumn 67, Issue 11, 1999, Pages 5848-5853

  Jiang, Chengyong ^a   Magee, D Mitchell ^a   Cox, Rebecca A ^a  

^a Texas Center for Infectious Disease   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; HLA A2 ANTIGEN; INTERLEUKIN 12;

ACTIVE IMMUNIZATION; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; COCCIDIOIDES IMMITIS; COCCIDIOIDOMYCOSIS; EXPRESSION VECTOR; FEMALE; GENE TARGETING; GENE THERAPY; HELPER CELL; HOST RESISTANCE; INFECTION RESISTANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

EID: 0032706265     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.67.11.5848-5853.1999     Document Type: Article

References (48)

1. Abuodeh, R. O., L. F. Shubitz, E. Siegel, S. Snyder, T. Peng, K. I. Osborn, E. Brummer, D. A. Stevens, and J. N. Galgiani. 1999. Resistance to Coccidioides immitis in mice after immunization with recombinant protein or a DNA vaccine of a proline-rich antigen. Infect. Immun. 67:2935-2940.
2. Afonso, L. C. C., T. M. Scharton, L. Q. Vieira, M. Wysocka, G. Trinchieri, and P. Scott. 1994. The adjuvant effect of interleukin 12 in a vaccine against Leishmania major. Science 263:235-237.
3. Ahlers, J. D., N. Dunlop, D. W. Alling, P. L. Nara, and J. A. Berzofsky. 1997. Cytokine-in-adjuvant steering of the immune response phenotype to HIV-1 vaccine constructs. Granulocyte-macrophage colony-stimulating factor and TNF-α synergize with IL-12 to enhance induction of cytotoxic T lymphocytes. J. Immunol. 158:3947-3958.
4. Ampel, N. M., G. C. Bejarano, S. D. Salas, and J. N. Galgiani. 1992. In vitro assessment of cellular immunity in human coccidioidomycosis: relationship between dermal hypersensitivity, lymphocyte transformation, and lymphokine production by peripheral blood mononuclear cells from healthy adults. J. Infect. Dis. 165:710-715.
5. Arulanandam, B. P., and D. W. Metzer. 1999. Modulation of mucosal and systemic immunity by intranasal interleukin 12 delivery. Vaccine 17:252-260.
6. Beaman, L. 1987. Fungicidal activation of murine macrophages by recombinant gamma interferon. Infect. Immun. 55:2951-2955.
7. Beaman, L., E. Benjamini, and D. Pappagianis. 1983. Activation of macrophages by lymphokines: enhancement of phagosome-lysosome fusion and killing of Coccidioides immitis. Infect. Immun. 39:1201-1207.
8. Beaman, L., D. Pappagianis, and E. Benjamini. 1977. Significance of T cells in resistance to experimental murine coccidioidomycosis. Infect. Immun. 17:580-585.
9. Chan, S. H., B. Perussia, J. W. Gupta, M. Kobayashi, M. Pospisil, H. A. Young, S. F. Wolf, D. Yong, S. C. Clark, and G. Trinchieri. 1991. Induction of interferon γ production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers. J. Exp. Med. 173:869-879.
10. Chow, Y.-H., B.-L. Chiang, Y.-L. Lee, W.-K. Chi, W.-C. Lin, Y.-T. Chen, and M.-H. Tao. 1998. Development of Th1 and Th2 populations and the nature of immune responses to hepatitis B virus DNA vaccines can be modulated by codelivery of various cytokine genes. J. Immunol. 160:1320-1329.
11. Corry, D. B., N. M. Ampel, L. Christian, R. M. Locksley, and J. N. Galgiani. 1996. Cytokine production by peripheral blood mononuclear cells in human coccidioidomycosis. J. Infect. Dis. 174:440-443.
12. Cox, R. A., and L. A. Britt. 1985. Antigenic heterogeneity of an alkali-soluble, water-soluble cell wall extract of Coccidioides immitis. Infect. Immun. 50: 365-369.
13. Cox, R. A., E. Brumer, and G. Lecara. 1977. In vitro lymphocyte responses of coccidioidin skin-test positive and -negative persons to coccidioidin, spherulin, and a Coccidioides immitis cell wall antigen. Infect. Immun. 15: 751-755.
14. Cox, R. A., W. Kennell, L. Boncyk, and J. W. Murphy. 1988. Induction and expression of cell-mediated immune responses in inbred mice infected with Coccidioides immitis. Infect. Immun. 56:13-17.
15. Cox, R. A., and D. M. Magee. 1998. Protective immunity in coccidioidomycosis. Res. Immunology 149:417-428.
16. Cox, R. A., and J. R. Vivas. 1977. Spectrum of in vivo and in vitro immune responses in coccidioidomycosis. Cell. Immunol. 31:130-141.
17. Dugger, K. O., K. M. Willareal, A. Ngyuen, C. R. Zimmermann, J. H. Law, and J. N. Galgiani. 1996. Cloning and sequence analysis of the cDNA for a protein from Coccidioides immitis with immunogenic potential. Biochem. Biophys. Res. Commun. 218:485-489.
18. Guery, J.-C., F. Galbiati, S. Smiroldo, and L. Adorini. 1996. Normal and β2-microglobulin-deficient BALB/c mice. J. Exp. Med. 183:485-497.
19. Irvine, K. R., J. B. Rao, S. A. Rosenberg, and N. P. Restifo. 1996. Cytokine enhancement of DNA immunization leads to effective treatment of established pulmonary metastases. J. Immunol. 156:238-245.
20. Jiang, C., D. M. Magee, T. N. Quitugua, and R. A. Cox. 1999. Genetic vaccination against Coccidioides immitis: comparison of vaccine efficacy of recombinant antigen 2 and antigen 2 cDNA. Infect. Immun. 67:630-635.
21. Jiang, C., D. M. Magee, and R. A. Cox. 1999. Construction of a single-chain interleukin-12-expressing retroviral vector and its application in cytokine gene therapy against experimental coccidioidomycosis. Infect. Immun. 67: 2996-3001.
22. Kim, J. J., V. Ayyavoo, M. L. Bagarazzi, M. A. Chattergoon, K. Dang, B. Wang, J. D. Boyer, and D. B. Weiner. 1997. In vivo engineering of a cellular immune response by co-administration of IL-12 expression vector with DNA immunogen. J. Immunol. 158:816-826.
23. Kirkland, T. N., F. Finley, K. I. Orsborn, and J. N. Galgiani. 1998. Evaluation of the proline-rich antigen of Coccidioides immitis as a vaccine candidate in mice. Infect. Immun. 66:3519-3522.
24. Kobayashi, M., L. Fitz, M. Ryan, R. M. Hewick, S. C. Clark, S. Chan, R. Loudon, F. Sherman, B. Perussia, and G. Trinchiera. 1989. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biological effects on human lymphocytes. J. Exp. Med. 170: 827-845.
25. Kong, Y. M., H. B. Levine, and C. E. Smith. 1963. Immunogenic properties of nondisrupted and disrupted spherules of Coccidioides immitis in mice. Sabouraudia 2:131-142.
26. Lecara, G., R. A. Cox, and R. B. Simpson. 1983. Coccidioides immitis vaccine: potential of an alkali-soluble, water-soluble cell wall antigen. Infect. Immun. 39:473-475.
27. Levine, H. B., J. M. Cobb, and C. E. Smith. 1961. Immunogenicity of spherule-endospore vaccines of Coccidioides immitis for mice. J. Immunol. 87:218-227.
28. Magee, D. M., and R. A. Cox. 1995. Roles of gamma interferon and interleukin-4 in genetically determined resistance to Coccidioides immitis. Infect. Immun. 63:3514-3518.
29. Magee, D. M., and R. A. Cox. 1996. Interleukin-12 regulation of host defenses against Coccidioides immitis. Infect. Immun. 64:3609-3613.
30. McKnight, A. J., G. J. Zimmer, I. Fogelman, S. F. Wolf, and A. K. Abbas. 1994. Effects of IL-12 on helper T cell-dependent immune responses in vivo. J. Immunol. 152:2172-2179.
31. Metzger, D. W., R. M. McNutt, J. T. Collins, J. M. Buchanan, V. H. V. Cleve, and W. A. Dunick. 1997. Interleukin-12 acts as an adjuvant for humoral immunity through interferon-γ-dependent and -independent mechanisms. Eur. J. Immunol. 27:1958-1965.
32. Mosmann, T. R., and R. L. Coffman. 1989. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:145-173.
33. Pappagianis, D., R. Hector, H. B. Levine, and M. S. Collins. 1979. Immunization of mice against coccidioidomycosis with a subcellular vaccine. Infect. Immun. 25:440-445.
34. Pappagianis, D., C. E. Smith, G. S. Kobayashi, and M. T. Saito. 1961. Studies of antigens from young mycelia at Coccidioides immilis. J. Infect. Dis. 108:35-44.
35. Schoenhaut, D. S., A. O. Chua, A. G. Wolitzky, M. Phyllis, P. M. Quinn, C. M. Dwyer, W. McComas, P. C. Familletti, M. K. Gately, and U. Gubler. 1992. Cloning and expression of murine IL-12. J. Immunol. 148:3433-3440.
36. Sin, J.-I., J. J. Kim, R. L. Arnold, K. E. Shroff, D. McCallus, C. Pachuk, S. P. McElhiney, M. W. Wolf, S. J. Pompa-de Bruin, T. J. Higgins, R. B. Ciccarelli, and D. B. Weiner. 1999. IL-12 gene as a DNA vaccine adjuvant in a herpes mouse model: IL-12 enhances Th1-type CD4+ T cell-mediated protective immunity against herpes simplex virus-2 challenge. J. Immunol. 162:2912-2921.
37. Stevens, D. A. 1995. Current concepts: coccidioidomycosis. N. Engl. J. Med. 332:1077-1082.
38. Sypek, J. P., C. L. Chung, S. E. H. Mayor, J. M. Subramanyam, S. J. Goldman, D. S. Sieburth, S. F. Wolf, and R. G. Schaub. 1993. Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type I immune response. J. Exp. Med. 177:1797-1802.
39. Tahara, H., L. Zitvogel, W. J. Storkus, H. J. Zeh III, T. G. McKinney, R. D. Schreiber, U. Gubler, P. D. Robbins, and M. T. Lotze. 1995 Effective eradication of established murine tumors with IL-12 gene therapy using a polycistronic retroviral vector. J. Immunol. 154:6466-6474.
40. Trinchieri, G. 1994. Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood 84:4008-4027.
41. Trinchieri, G. 1995. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 152:1883-1887.
42. Tsuji, T., K. Hamajima, J. Fukushima, K.-Q. Xin, N. Ishii, I. Aoki, Y. Ishigatsubo, K. Tani, S. Kawamoto, Y. Nitta, J.-I. Miyazaki, W. C. Koff, T. Okubo, and K. Okuda. 1997. Enhancement of cell-mediated immunity against HIV-1 induced by coinoculation of plasmid-encoded HIV-1 antigen with plasmid expressing IL-12. J. Immunol. 158:4008-4013.
43. Wynn, T. A., A. W. Cheever, D. Jankovic, R. W. Poindexter, P. Caspar, F. A. Lewis, and A. Sher. 1995. An IL-12 based vaccination method for preventing fibrosis induced by schistosome infection. Nature 376:594-596.
44. Wynn, T. A., D. Jankovic, S. Hieny, A. W. Cheever, and A. Sher. 1995. IL-12 enhances vaccine-induced immunity to Schistosoma mansoni in mice and decreases T helper 2 cytokine expression, IgE production, and tissue eosinophilia. J. Immunol. 154:4701-4709.
45. Zatloukal, K., A. Schneeberger, M. Berger, W. Schmidt, F. Koszik, R. Kutil, M. Cotton, E. Wagner, M. Buschle, G. Maass, E. Payer, G. Stingl, and M. L. Birnstiel. 1995. Elicitation of a systemic and protective anti-melanoma immune response by an IL-12 based vaccine. J. Immunol. 154:3406-3419.
46. Zhou, P., M. C. Sieve, J. Bennett, K. J. Kwon-Chung, R. P. Tewari, R. T. Gazzinelli, A. Sher, and R. A. Seder. 1995. IL-12 prevents mortality in mice infected with Histoplasma capsulatum through induction of IFN-γ. J. Immunol. 155:785-795.
47. Zhu, Y., C. Yang, D. M. Magee, and R. A. Cox. 1996. Coccidioides immitis antigen 2: analysis of gene and protein. Gene 181:121-125.
48. Zhu, Y., C. Yang, D. M. Magee, and R. A. Cox. 1996. Molecular cloning and characterization of Coccidioides immitis antigen 2 cDNA. Infect. Immun. 64:2695-2699.